DNA X, Inc. (SONM) — Financial statements
Income statement, balance sheet, and cash flow for DNA X, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 58↓37.7% | 94↑34.1% | 70↑28.0% | 55 | |
| Cost of Revenue | 4↓91.1% | 48↓34.9% | 74↑27.7% | 58↑20.9% | 48 | |
| Gross Profit | -4↓143.3% | 10↓48.7% | 19↑66.3% | 12↑81.2% | 6 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00↓100.0% | 14↑703.3% | 2↓77.8% | 8↓54.9% | 18 | |
| General & Administrative Expenses | 5↓56.3% | 12↑49.7% | 8↓22.5% | 11↓37.8% | 17 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 13↑47.8% | 9↑20.5% | 7↓24.0% | 10 | |
| SG&A Expenses | 5↓78.7% | 25↑48.8% | 17↓5.0% | 18↓32.9% | 27 | |
| Other Expenses | -4↓208.1% | 4 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 1↓97.5% | 44↑131.6% | 19↓27.4% | 26↓41.7% | 44 | |
| Total Costs & Expenses | 5↓94.1% | 92↓1.3% | 93↑10.7% | 84↓9.1% | 93 | |
| Operating Results | ||||||
| Operating Income | -5↑83.9% | -34↓6657.3% | 0.51↑103.6% | -14↑62.4% | -38 | |
| Depreciation & Amortization | 4↑20.9% | 4↑61.2% | 2↓7.1% | 2↑11.6% | 2 | |
| EBITDA | -1↑96.3% | -30↓1291.1% | 3↑121.9% | -11↑68.5% | -36 | |
| EBIT | -6↑80.6% | -33↓11268.2% | 0.30↑102.2% | -14↑64.1% | -38 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1↓5024.1% | -0.03↓93.3% | -0.02↑84.5% | -0.10 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | -1↓5224.1% | 0.03↑93.3% | 0.02↓84.5% | 0.10 | 0.00 | |
| Non-Operating Income | 1↑532.1% | -0.25↓215.0% | 0.21↑144.2% | -0.48↓205.4% | 0.46 | |
| Other Income / Expenses | -3↓1274.7% | 0.22↑194.8% | -0.23↓159.2% | 0.39↑184.3% | -0.46 | |
| Income Before Tax | -8↑76.2% | -33↓11868.3% | 0.28↑102.0% | -14↑63.9% | -38 | |
| Income Tax Expense | 0.00↓100.0% | 0.23↓39.6% | 0.37↑103.3% | 0.18↑10.2% | 0.17 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -8↑76.4% | -34↓37286.7% | -0.09↑99.4% | -14↑63.5% | -39 | |
| Net Income from Discontinued Operations | -13 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -21↑38.6% | -34↓37286.7% | -0.09↑99.4% | -14↑63.5% | -39 | |
| Bottom-Line Net Income | -21↑38.6% | -34↓37286.7% | -0.09↑99.4% | -14↑63.5% | -39 | |
| EPS (Basic) | -28.58↓300.8% | -7.13↓33852.4% | -0.02↑99.6% | -4.88↑88.0% | -40.81 | |
| EPS (Diluted) | -1.59↑77.7% | -7.13↓33852.4% | -0.02↑99.6% | -4.88↑88.0% | -40.81 | |
| Weighted Average Shares | 0.72↓84.7% | 5↑10.0% | 4↑48.4% | 3↑205.2% | 0.95 | |
| Weighted Average Diluted Shares | 13↑175.7% | 5↑10.0% | 4↑48.4% | 3↑205.2% | 0.95 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.